Bank of America’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-87,846
| Closed | -$8.96M | – | 6990 |
|
|
2023
Q2 | $8.96M | Sell |
87,846
-133,850
| -60% | -$13.6M | ﹤0.01% | 2388 |
|
|
2023
Q1 | $20.2M | Buy |
221,696
+18,685
| +9% | +$1.7M | ﹤0.01% | 1830 |
|
|
2022
Q4 | $7.71M | Buy |
203,011
+32,475
| +19% | +$1.23M | ﹤0.01% | 2501 |
|
|
2022
Q3 | $4.29M | Buy |
170,536
+81,795
| +92% | +$2.06M | ﹤0.01% | 2953 |
|
|
2022
Q2 | $2.7M | Buy |
88,741
+10,609
| +14% | +$322K | ﹤0.01% | 3478 |
|
|
2022
Q1 | $2.56M | Sell |
78,132
-17,086
| -18% | -$560K | ﹤0.01% | 3772 |
|
|
2021
Q4 | $2.51M | Buy |
95,218
+6,607
| +7% | +$174K | ﹤0.01% | 3712 |
|
|
2021
Q3 | $8.92M | Buy |
88,611
+29,158
| +49% | +$2.93M | ﹤0.01% | 2575 |
|
|
2021
Q2 | $8.42M | Sell |
59,453
-22,776
| -28% | -$3.22M | ﹤0.01% | 2604 |
|
|
2021
Q1 | $8.2M | Buy |
82,229
+16,971
| +26% | +$1.69M | ﹤0.01% | 2579 |
|
|
2020
Q4 | $8.07M | Buy |
65,258
+3,905
| +6% | +$483K | ﹤0.01% | 2344 |
|
|
2020
Q3 | $5.98M | Sell |
61,353
-2,699
| -4% | -$263K | ﹤0.01% | 2427 |
|
|
2020
Q2 | $10M | Sell |
64,052
-31,080
| -33% | -$4.85M | ﹤0.01% | 1983 |
|
|
2020
Q1 | $13.7M | Buy |
95,132
+3,366
| +4% | +$486K | ﹤0.01% | 1601 |
|
|
2019
Q4 | $18.8M | Buy |
91,766
+3,212
| +4% | +$657K | ﹤0.01% | 1674 |
|
|
2019
Q3 | $7.11M | Buy |
88,554
+25,280
| +40% | +$2.03M | ﹤0.01% | 2437 |
|
|
2019
Q2 | $5.97M | Sell |
63,274
-2,144
| -3% | -$202K | ﹤0.01% | 2610 |
|
|
2019
Q1 | $5.59M | Sell |
65,418
-9,014
| -12% | -$770K | ﹤0.01% | 2645 |
|
|
2018
Q4 | $4.18M | Buy |
74,432
+64,454
| +646% | +$3.62M | ﹤0.01% | 2740 |
|
|
2018
Q3 | $816K | Buy |
9,978
+4,244
| +74% | +$347K | ﹤0.01% | 3977 |
|
|
2018
Q2 | $200K | Sell |
5,734
-602
| -10% | -$21K | ﹤0.01% | 4712 |
|
|
2018
Q1 | $129K | Buy |
6,336
+1,958
| +45% | +$39.9K | ﹤0.01% | 4887 |
|
|
2017
Q4 | $124K | Buy |
4,378
+2,613
| +148% | +$74K | ﹤0.01% | 4875 |
|
|
2017
Q3 | $55K | Buy |
1,765
+750
| +74% | +$23.4K | ﹤0.01% | 5109 |
|
|
2017
Q2 | $32K | Sell |
1,015
-112
| -10% | -$3.53K | ﹤0.01% | 5298 |
|
|
2017
Q1 | $26K | Buy |
1,127
+345
| +44% | +$7.96K | ﹤0.01% | 5461 |
|
|
2016
Q4 | $17K | Buy |
782
+545
| +230% | +$11.8K | ﹤0.01% | 5623 |
|
|
2016
Q3 | $6K | Sell |
237
-16,300
| -99% | -$413K | ﹤0.01% | 5779 |
|
|
2016
Q2 | $327K | Buy |
+16,537
| New | +$327K | ﹤0.01% | 4203 |
|